Back

Days lost by death and hospitalization in patients with durable left ventricular assist device

31 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Multidisciplinary approach to heart failure Ventricular Assist Devices ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Toru Kondo

Nagoya University Graduate School of Medicine, Nagoya (Japan)

6 More presentations in this session

Presentation thumbnail
Guideline-directed medical therapy presciption after acute heart failure hospitalization in Japan
Mr K. Kanaoka (Suita, JP)
Abstract Slides Video
Presentation thumbnail
New horizons in transthyretin cardiac amyloidosis therapy: A systematic review and meta-analysis of sodium-glucose cotransporter 2 inhibitors efficacy
Doctor M. Chacon Quiros (San Jose, CR)
Abstract Slides Video
Presentation thumbnail
Effects of early empagliflozin in acute decompensated HFrEF on ventricular systolic and diastolic parameters: interaction with endothelial function and arterial stiffness
Doctor O. Katsarou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Off-label low-dose therapy in heart failure reduced ejection fraction: can we achieve the benefits of the four pillars?
Doctor M. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Cardiovascular effects of preferred HOMe-based EXercise training and extended adherence measures in systolic heart failure
Doctor M. Bahls (Greifswald, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Multidisciplinary approach to heart failure

The Event

Event poster

ESC Congress 2025

31 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Vutrisiran reduces days lost to death and/or hospitalization versus placebo in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial
31 August 2025
thumbnail
Congress Presentation
Ultra-long LVAD recipients: a new heart failure phenotype?
19 May 2025
thumbnail
Congress Presentation
Causes and prognostic implications of hospital admissions following successful heart transplantation
17 May 2025
thumbnail
Congress Presentation
Discharge prescription for neurohormonal blockade and clinical outcomes in HeartMate 3 LVAD recipients after device implantation
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources